T0	Limitation 18357 18363	First,
T1	Limitation 18539 18546	Second,
T2	Limitation 18819 18825	Third,
T3	Limitation 19130 19137	Fourth,
T4	Population 18364 18426	mortality in the placebo group was much lower than anticipated
T5	MissingData 18590 18676	we did not obtain prospective data for cardiovascular comorbidity and causes of deaths
T6	SampleSize 18826 18889	the trial was stopped at a smaller sample size than was planned
T7	NonstandardTreatmentCharacteristics 19242 19291	we did not measure details of clinical management
T8	UnderpoweredStudy 18902 18972	the precision of the treatment effect estimates is lower than expected
T9	Limitation 19946 19947	A
T10	Generalization 20017 20081	the conclusions from our study can relate only to the dose given
